What do patients learn during long antibiotic treatment? UAC's first Visiting Fellow explores the patient perspective

Visiting Fellow Monia Torre with host researcher Mirko Ancillotti
Monia Torre, social anthropologist and science communicator at the Italian National Research Council (CNR) and the National Institute for Infectious Diseases "Lazzaro Spallanzani" in Rome, spent four weeks in Uppsala this autumn as the first researcher hosted through the UAC Visiting Fellows program. Her host was Mirko Ancillotti at the Centre for Research Ethics and Bioethics (CRB).
One patient Monia interviewed entered her own antibiogram results into AI tools during her hospital stay. She wanted to check her doctors' treatment choices and keep a sense of control over her situation.
"This highlights our responsibility to involve patients and give them tools to understand properly," says Monia. "They take the initiative to understand what is happening to them in any case."
A type of patient missing from antibiotic stewardship
Monia and Mirko study a group that AMR research rarely focuses on: hospitalized patients on prolonged antibiotic treatment for serious infections. Most work on patient engagement in antibiotic stewardship comes from primary care, but we know very little about patients receiving long treatments.
Their starting point is the idea of a "teachable moment". A long hospital stay for a bacterial infection could be the time when people become most open to understanding antibiotics and resistance. Patients experience the disease first-hand, over several weeks, and talk to healthcare staff every day.
Interviews at the Spallanzani Institute suggest this moment is often missed. Early findings include:
- Awareness stays low. Even after more than two weeks in hospital, patients rarely understand AMR better than they did when they arrived.
- Staff rotation affects trust. Seeing a different doctor each day makes it harder for patients to build trust and feel involved.
- Patients differ. Some actively seek information and some prefer not to know. Others want information but can't get it.
- The path to diagnosis is fragmented. Before admission, patients often go through complex diagnostic routes and rely heavily on personal networks to get answers. "This reflects how difficult it is to address infectious diseases and AMR at the local level," says Monia.
- Uncertainty shapes the experience. Often patients live with uncertainty about how they got infected contributing to a sense of helplessness about how to prevent reinfection.
These aspects provide insights, both into how we conceptualize doctor–patient communication in the context of antimicrobial stewardship and into how we approach public communication on this issue.
Four weeks of focused work
The visit let the two researchers push their joint work forward in person. "Her visit helped us make progress on our joint work: we have almost finalized one paper and started another," says Mirko.
The first paper covers communication and patient engagement, while the second takes a bioethical perspective built on the concept of patient autonomy. Together they will form a framework describing how much decision-making power patients can have in stewardship.
A question that changed the framing
Monia presented the work at the UAC Science Club and at the Open Higher Seminars at CRB. The bioethics seminar sharpened the theoretical framework. At the UAC Science Club, researchers who work on antibiotics and resistance from very different angles questioned assumptions that the pair had taken for granted.
One question stuck in particular. "In my mind, shared decision-making was already the goal," says Monia. "Then I was asked: why should we engage patients at all? It helped us take a step back and frame the work in a way that is understandable to others."
For Mirko, her background mattered too. The visit "gave colleagues an opportunity to engage with her anthropological perspective, which brought a different background and approach to our discussions."
Next steps
Mirko and Monia will now finalize both manuscripts, and then try to test the framework beyond Italy. Sweden and Italy differ in how the public understands AMR and in how stewardship programs are organized, so a comparison could be revealing. They are exploring European and national funding calls.
This was Monia's second stay at CRB. The collaboration began during her first, a year ago, through an Italian mobility scheme. "You cannot know who you will meet there. So, it's a very important opportunity." she says.
"Having time to work together in person can make a real difference to a collaboration, and a programme like the UAC Visiting Fellows makes that possible," says Mirko.
About the Visiting Fellows program at UAC
The program funds short research visits to Uppsala that start or strengthen collaborations on antimicrobial resistance.
- Who can apply: Members of the UAC Research Community who want to host an external researcher
- What it covers: Travel, accommodation, and other visit-related costs, up to 50,000 SEK per application.
- How to apply: write to UAC coordinator eva.garmendia@uac.uu.se to get actual application dates.